News Note · IDAEO AI News

#News media

10/20《生技股動態》-環球生技月刊

Original-language title

Publisher:

TL;DR · What this means

✔ 仁新(6696)LBS-007澳洲急性白血病一/二期臨床試驗設計變更案,獲澳洲TGA確認進行

(Excerpt from the original lead, not a rewrite)

Story Text

Full English translation is in progress; the text below is the original.

市場觀測:

✔ 仁新(6696)LBS-007澳洲急性白血病一/二期臨床試驗設計變更案,獲澳洲TGA確認進行

✔ 安盛生(6734)伊必測排卵檢測系統取得歐盟IVDR准證

✔ 亞灣醫(7435)10/23起登錄創櫃板

✔ 全福生技(6885)董事會決議辦理現增案,上限3900萬股

10/20一日漲跌

(漲)泰合89.57%、浩宇生醫9.82%、欣大健康5.19%

(跌)杏國6.54%、漢達6.16%、益安4.31%

https://reurl.cc/k9Y179

10/20 法人動態

(買超)松瑞藥543張、康霈*445張、泰合421張;

(賣超)沛爾生醫*-創1816張、漢達233張、聯合129張

https://reurl.cc/OQ3Ak9

市場即時觀測:

http://bit.ly/bio-invest

新聞集錦

投資雷達

Citation-ready facts (F-Units)

✔ 仁新(6696)LBS-007澳洲急性白血病一/二期臨床試驗設計變更案,獲澳洲TGA確認進行

F1 Original sentence as captured by this site (only formatting marks and extra spaces removed), paragraph 2 · news.gbimonthly.com Source type: unclassified (not verified)

✔ 安盛生(6734)伊必測排卵檢測系統取得歐盟IVDR准證

F2 Original sentence as captured by this site (only formatting marks and extra spaces removed), paragraph 3 · news.gbimonthly.com Source type: unclassified (not verified)

✔ 亞灣醫(7435)10/23起登錄創櫃板

F3 Original sentence as captured by this site (only formatting marks and extra spaces removed), paragraph 4 · news.gbimonthly.com Source type: unclassified (not verified)

✔ 全福生技(6885)董事會決議辦理現增案,上限3900萬股

F4 Original sentence as captured by this site (only formatting marks and extra spaces removed), paragraph 5 · news.gbimonthly.com Source type: unclassified (not verified)

(漲)泰合89.57%、浩宇生醫9.82%、欣大健康5.19%

F5 Original sentence as captured by this site (only formatting marks and extra spaces removed), paragraph 7 · news.gbimonthly.com Source type: unclassified (not verified)

Frequently Asked Questions (FAQ)

這則新聞的重點是什麼?

✔ 仁新(6696)LBS-007澳洲急性白血病一/二期臨床試驗設計變更案,獲澳洲TGA確認進行

原文提到哪些關鍵數字?

✔ 安盛生(6734)伊必測排卵檢測系統取得歐盟IVDR准證 ✔ 亞灣醫(7435)10/23起登錄創櫃板

這則新聞的原始出處與發布時間?

原始出處:news.gbimonthly.com(https://news.gbimonthly.com/tw/invest/show.php?num=90833&kind=20)。原文發布時間:2026-10-20。